primary ovarian insufficiency: Absent or premature cessation of ovarian function due to a pathologic process originating within the ovaries.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleonly females |
293373 |
2. Check conditionsNone |
293373 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
3 out of 7 registries used, show all original rules. |
722 |
4. Check minimum number of eventsNone |
722 |
5. Include endpointsNone |
722 |
6. Filter based on genotype QC (FinnGen only) |
722 |
Control definitions (FinnGen only)
- Control exclude
- E4_ENDOGLAND
Extra metadata
- Level in the ICD hierarchy
- 4
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- E28
- Name in latin
- Insufficientia ovariorum primaria
Similar endpoints
↥List of similar endpoints to
Primary ovarian failure
based on the number of shared cases.
Similar with more cases:
- Ovarian dysfunction
- Disorders of other endocrine glands
- Endocrine, nutritional and metabolic diseases
- Any event in hilmo or specialist outpatient
- Any prescribed medicine buy
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 2798 | 2798 | - |
| Only index persons | 2690 | 2690 | - |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.08 | 0.08 | - |
| Only index persons | 0.10 | 0.10 | - |
| Median age at first event (years) | |||
| Whole population | - | 36.22 | - |
| Only index persons | - | 36.17 | - |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 722 | 722 | - |
| Unadjusted period prevalence (%) | 0.25 | 0.25 | - |
| Median age at first event (years) | 37.87 | 37.87 | - |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 644
- Matched controls
- 6440
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
E28.3
ICD-10 Finland
Primary ovarian failure
2317.7
323.0
336
*
121
Kela drug reimbursment
Severe hypofunction of sexual glands
264.2
323.0
419
45
G03CA03
ATC
estradiol; nasal, systemic, rectal, transdermal, vaginal
6.2
97.0
483
2089
G03FB08
ATC
dydrogesterone and estrogen; systemic (progestogens and estrogens, sequential prep.)
10.1
91.8
201
276
N91.1
ICD-10 Finland
Secondary amenorrhoea
18.1
61.7
98
63
25610
ICD-8 Finland
Ovarian dysfunction, Hypofunction
+∞
60.4
57
*
G03FB06
ATC
medroxyprogesterone and estrogen; systemic (progestogens and estrogens, sequential prep.)
8.7
55.7
128
178
G03FB05
ATC
norethisterone and estrogen; systemic (progestogens and estrogens, sequential prep.)
5.8
51.6
165
363
G03DB01
ATC
dydrogesterone; oral
3.6
40.9
229
848
G03FA01
ATC
norethisterone and estrogen; systemic (progestogens and estrogens, fixed comb.)
4.0
32.3
145
434
E28.8
ICD-10 Finland
Other ovarian dysfunction
293.6
28.0
28
*
E28.9
ICD-10 Finland
Ovarian dysfunction, unspecified
+∞
25.2
24
*
N97.8
ICD-10 Finland
Female infertility of other origin
7.0
24.4
62
97
LC2BE
NOMESCO Finland
Transvaginal ultrasound examination of uterus, parametria and lower abdomen
2.3
23.0
336
2058
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
2.5
21.9
217
1083
E28.2
ICD-10 Finland
Polycystic ovarian syndrome
32.4
21.6
28
9
G03DA02
ATC
medroxyprogesterone; systemic (pregnen (4) derivatives)
3.7
19.8
93
283
G03FA12
ATC
medroxyprogesterone and estrogen; systemic (progestogens and estrogens, fixed comb.)
4.3
18.5
71
180
NK6QA
NOMESCO Finland
Measurement of bone density from tow or more locations with X-ray
4.7
18.1
63
145
E23.00
ICD-10 Finland
Panhypopituitarism
+∞
17.8
17
*
N91.0
ICD-10 Finland
Primary amenorrhoea
97.8
17.6
19
*
H02AB09
ATC
hydrocortisone; systemic
10.5
17.1
33
33
G03GA02
ATC
human menopausal gonadotrophin; parenteral
4.4
15.9
59
145
101
Kela drug reimbursment
Anterior pituitary hypofunction
+∞
15.7
15
*
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.1
15.6
230
1343
L04AA01
ATC
[U] ciclosporin; systemic
11.2
14.1
26
24
N91.4
ICD-10 Finland
Secondary oligomenorrhoea
16.2
14.0
22
14
G03FB09
ATC
levonorgestrel and estrogen; systemic (progestogens and estrogens, sequential prep.)
7.7
13.6
31
42
N80.1
ICD-10 Finland
Endometriosis of ovary
3.8
13.6
59
168
N97.0
ICD-10 Finland
Female infertility associated with anovulation
5.1
12.7
40
83
KBV02
NOMESCO Finland
Cystoscopic insertion of stent into ureter
9.0
12.6
26
30
LAF10
NOMESCO Finland
Bilateral salpingo-oophorectomy
5.4
12.5
37
72
G03DA04
ATC
progesterone; systemic, rectal, vaginal
3.6
12.3
56
166
LC2AE
NOMESCO Finland
Ultrasound examination of uterus and parametria
2.2
12.2
139
716
N80.4
ICD-10 Finland
Endometriosis of rectovaginal septum and vagina
6.6
12.0
30
47
LCD00
NOMESCO Finland
Hysterectomy
3.5
11.7
55
167
N95.1
ICD-10 Finland
Menopausal and female climacteric states
2.3
11.6
122
603
H01AC01
ATC
somatropin; parenteral
122.1
11.5
12
*
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
2.5
11.4
95
418
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
2.0
11.1
170
985
O80.0
ICD-10 Finland
Spontaneous vertex delivery
0.5
10.6
138
2192
127
Kela drug reimbursment
Transplant complication
10.3
10.6
20
20
E27.1
ICD-10 Finland
Primary adrenocortical insufficiency
+∞
10.4
10
*
E
ICD-9 Finland
NA
23.8
10.3
14
6
A02BC02
ATC
pantoprazole; systemic
1.7
10.3
396
3087
H03AA01
ATC
levothyroxine sodium; systemic
1.9
10.2
181
1102
N83.2
ICD-10 Finland
Other and unspecified ovarian cysts
2.2
10.1
117
602
N80.3
ICD-10 Finland
Endometriosis of pelvic peritoneum
3.2
10.1
52
170
G03FA14
ATC
dydrogesterone and estrogen; systemic (progestogens and estrogens, fixed comb.)
2.6
9.9
73
301
B01AB05
ATC
enoxaparin; parenteral
1.9
9.8
175
1068
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
1.8
9.6
231
1553
N02AA05
ATC
oxycodone; systemic
2.7
9.6
67
268
105
Kela drug reimbursment
Adrenal cortical hypofunction
+∞
9.4
9
*
E23.04
ICD-10 Finland
Hypogonadotropic hypogonadism
+∞
9.4
9
*
G03GA01
ATC
chorionic gonadotrophin; parenteral
2.8
9.3
61
232
H02AB06
ATC
prednisolone; systemic
1.7
9.2
289
2091
A02BC05
ATC
esomeprazole; systemic
1.7
9.1
249
1732
G02BA03
ATC
plastic IUD with progestogen
0.4
9.1
48
1030
N91.2
ICD-10 Finland
Amenorrhoea, unspecified
15.9
9.1
14
9
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
5.2
9.0
27
54
Z30.1
ICD-10 Finland
Insertion of (intrauterine) contraceptive device
0.4
8.9
40
909
Z34.8
ICD-10 Finland
Supervision of other normal pregnancy
0.4
8.7
55
1109
LAF00
NOMESCO Finland
Unilateral salpingo-oophorectomy
5.3
8.5
25
49
H02AA02
ATC
fludrocortisone; oral
20.3
8.5
12
6
L03AA02
ATC
filgrastim; parenteral
5.2
8.4
25
50
Z3226
NOMESCO Finland
Physiotherapist
2.0
8.4
112
610
102
Kela drug reimbursment
Diabetes insipidus
+∞
8.3
8
*
E22.1
ICD-10 Finland
Hyperprolactinaemia
+∞
8.3
8
*
TPW99
NOMESCO Finland
Other minor surgical procedure on peripheral vessel or lymphatic system
10.9
8.3
15
14
ZXE10
NOMESCO Finland
More than one and less than three hours
1.7
8.1
214
1463
Z31.5
ICD-10 Finland
Genetic counselling
2.5
8.1
61
254
7890A
ICD-9 Finland
Other symptoms involving abdomen and pelvis, Abdominal pain
2.8
8.0
51
194
C03CA01
ATC
furosemide; systemic
2.2
7.9
87
436
W12
ICPC
Contraception intrauterine
0.4
7.9
27
686
G03FB01
ATC
norgestrel and estrogen; systemic (progestogens and estrogens, sequential prep.)
9.6
7.8
15
16
N80.9
ICD-10 Finland
Endometriosis, unspecified
3.7
7.8
32
89
1413
FHL
Laparoscopy and other therapeutic procedure
4.1
7.8
29
74
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
5.3
7.6
22
43
N80.5
ICD-10 Finland
Endometriosis of intestine
10.2
7.6
14
14
G03DC02
ATC
norethisterone; oral
2.1
7.5
91
478
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
2.3
7.4
68
313
XLD00
NOMESCO Finland
Sytologyspecimen from mouth of uterus
1.8
7.4
129
770
A12AA04
ATC
calcium carbonate; oral
13.6
7.4
12
9
N80.81
ICD-10 Finland
Endometriosis in sacrouteral ligament
11.0
7.3
13
12
E30.09
ICD-10 Finland
Delayed puberty NOS
+∞
7.3
7
*
N73.6
ICD-10 Finland
Female pelvic peritoneal adhesions
5.3
7.3
21
41
E89.4
ICD-10 Finland
Postprocedural ovarian failure
30.4
7.2
9
*
E03.9
ICD-10 Finland
Hypothyroidism, unspecified
2.1
7.1
84
436
JAH01
NOMESCO Finland
Laparoscopy
2.6
7.1
50
203
UKC02
NOMESCO Finland
Cystoscopy
2.4
7.0
58
256
H01CA02
ATC
nafarelin; nasal
2.8
7.0
44
164
8113
FHL
Fractional scraping
3.1
7.0
36
120
Z31.2
ICD-10 Finland
In vitrofertilization
6.4
7.0
17
27
R4110
NOMESCO Finland
Physiotherapy
1.7
6.9
149
953
L04AD01
ATC
ciclosporin; systemic
5.1
6.8
20
40
JAL96
NOMESCO Finland
Other excision of lesion of peritoneum
22.8
6.7
9
*
WX408
NOMESCO Finland
General anesthesy, balanced
1.7
6.7
163
1080
P01BA02
ATC
hydroxychloroquine; oral
2.3
6.6
63
296
I25.1
ICD-10 Finland
Atherosclerotic heart disease
2.9
6.6
39
142
130
Kela drug reimbursment
Malignant tumour
3.3
6.6
31
97
KBV10
NOMESCO Finland
Removal of stent from ureter
8.8
6.6
13
15
G03DC05
ATC
[U] tibolone; oral
3.8
6.5
26
71
Z31.6
ICD-10 Finland
General counselling and advice on procreation
7.0
6.5
15
22
A02BC01
ATC
omeprazole; systemic
1.7
6.5
146
942
N97.9
ICD-10 Finland
Female infertility, unspecified
2.1
6.5
69
341
JN4BD
NOMESCO Finland
Extensive body CT
2.5
6.5
49
206
G03GA06
ATC
follitropin beta; parenteral
2.9
6.5
38
138
UJF32
NOMESCO Finland
Coloscopy
1.8
6.5
126
782
LX1AE
NOMESCO Finland
Gynecological ultrasound examination as part of clinical examination
1.8
6.5
116
698
M01AH02
ATC
rofecoxib; oral
2.2
6.4
66
322
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
2.3
6.4
59
274
J01EE01
ATC
sulfamethoxazole and trimethoprim; systemic
2.7
6.4
41
157
Z01.4
ICD-10 Finland
Gynaecological examination (general)(routine)
1.7
6.3
164
1101
G03DC03
ATC
lynestrenol; oral
3.3
6.3
29
90
106
Kela drug reimbursment
Hypoparathyroidism
+∞
6.3
6
*
E34.9
ICD-10 Finland
Endocrine disorder, unspecified
+∞
6.3
6
*
A11CC02
ATC
dihydrotachysterol; oral
26.9
6.2
8
*
R50.9
ICD-10 Finland
Fever, unspecified
2.0
6.2
83
449
Z09.0
ICD-10 Finland
Follow-up examination after surgery for other conditions
2.1
6.2
69
348
UJG02
NOMESCO Finland
Proctoscopy
5.8
6.2
16
28
XF400
NOMESCO Finland
ECG with 12 standard connections
2.1
6.2
71
364
JAP01
NOMESCO Finland
Laparoscopic freeing of adhesions in the peritoneal cavity
4.3
6.2
21
50
L02AE02
ATC
leuprorelin; implant, parenteral
3.8
6.1
24
65
TPH90
NOMESCO Finland
Removal of fixed intravenous catheter
6.8
6.1
14
21
6202X
ICD-9 Finland
Noninflammatory disorders of ovary, Fallopian tube and broad ligament, Other and unspecified ovarian cyst
5.3
6.0
17
33
Z35.0
ICD-10 Finland
Supervision of pregnancy with history of infertility
2.6
6.0
40
158
WX002
NOMESCO Finland
Sedation and analgesia
1.8
6.0
101
596
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma
125
190
7.75
81.20
1.8
1.3
nmol/l
0.2
0.5
2.26
99
156
(40765089) Chromosome analysis panel - Blood by G-banded
57
25
24.67
79.26
1.0
1.0
—
—
—
0
0
(3009214) Lutropin [Units/volume] in Serum or Plasma
126
203
7.31
77.50
1.7
1.2
u/l
30.6
12.7
5.21
105
160
(3030313) Adrenal Ab [Titer] in Serum
64
5
140.20
60.92
1.1
1.2
—
—
—
0
0
(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma
103
187
6.26
55.81
1.5
1.4
ug/l
1.2
2.9
1.79
46
171
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
33
39
8.82
25.94
1.2
1.4
—
—
—
0
0
(3023323) Follitropin [Units/volume] in Serum or Plasma
154
652
2.73
24.47
2.1
1.3
iu/l
50.7
28.1
6.13
131
557
(3036481) Cortisol [Moles/volume] in Serum or Plasma
125
558
2.50
17.44
2.5
1.8
nmol/l
382.7
373.8
0.11
118
517
(3021387) Prolactin [Units/volume] in Serum or Plasma
98
391
2.74
17.15
1.5
1.3
mu/l
236.2
298.6
2.20
92
345
(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma
37
77
5.01
17.01
1.8
4.5
u/ml
509.9
96.5
—
8
26
(3035637) Corticotropin [Mass/volume] in Plasma
27
46
6.06
15.35
1.9
1.4
—
—
—
0
0
(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum
40
102
4.09
14.32
1.1
1.1
iu/ml
3.0
4719.9
—
5
27
(42870588) Differential panel, method unspecified - Blood
282
1839
1.88
14.29
7.1
5.5
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
136
684
2.22
14.27
1.3
1.2
iu/ml
105.4
153.2
0.82
42
288
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
307
2074
1.84
13.77
8.1
4.5
mmol/l
1.2
1.2
0.55
287
1894
(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay
54
176
3.24
13.48
2.0
1.4
u/l
44.0
24.4
3.92
54
148
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
336
2363
1.79
12.96
8.9
5.0
mmol/l
1.2
1.2
0.30
287
2006
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
533
4325
1.89
12.47
8.9
6.3
u/l
75.2
73.2
0.62
504
4070
(3024561) Albumin [Mass/volume] in Serum or Plasma
293
2030
1.75
11.52
5.9
4.1
g/l
36.5
36.8
0.45
272
1902
(3000991) Gas panel - Venous blood
67
273
2.60
11.17
8.4
8.4
—
—
—
0
0
(3015377) Calcium [Moles/volume] in Serum or Plasma
259
1745
1.76
11.16
4.1
3.0
mmol/l
2.3
2.3
0.11
232
1588
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
368
2733
1.71
11.13
6.9
5.2
umol/l
8.8
9.6
1.75
346
2578
(3013115) Eosinophils [#/volume] in Blood
407
3131
1.69
10.58
7.1
5.6
e9/l
0.2
0.2
1.09
372
2812
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
141
802
1.94
10.41
3.2
2.8
ng/l
22.1
175.4
2.85
91
424
(3037522) Nuclear Ab [Titer] in Serum
166
997
1.86
10.38
1.5
1.4
titre
1002.1
559.4
0.99
39
215
(3013650) Neutrophils [#/volume] in Blood by Automated count
439
3458
1.69
10.32
10.3
8.1
e9/l
3.9
3.9
0.15
393
3049
(3018418) pH of Serum or Plasma
215
1400
1.76
10.28
6.0
3.1
ph
7.4
7.4
0.54
38
258
(3001604) Monocytes [#/volume] in Blood
390
2994
1.66
9.98
7.1
5.4
e9/l
0.5
0.5
0.34
353
2656
(3006315) Basophils [#/volume] in Blood
391
3010
1.65
9.85
6.9
5.4
e9/l
0.0
0.0
0.02
354
2664
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
605
5263
1.92
9.56
5.7
4.3
pmol/l
14.6
14.2
4.00
582
4953
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
336
2522
1.62
9.12
2.6
2.2
nmol/l
76.3
75.5
0.21
313
2340
(3012095) Magnesium [Moles/volume] in Serum or Plasma
124
706
1.91
9.06
4.1
3.2
mmol/l
0.8
0.8
1.52
118
671
(3019198) Lymphocytes [#/volume] in Blood
398
3118
1.62
9.03
7.1
5.3
e9/l
2.0
2.0
0.19
366
2821
(3006504) Eosinophils/100 leukocytes in Blood
365
2816
1.60
8.70
7.1
5.4
%
2.5
2.7
1.46
351
2628
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
35
115
3.15
8.66
1.7
1.2
—
—
—
0
0
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
278
2013
1.62
8.61
3.4
2.8
u/l
27.9
27.6
0.08
271
1924
(3019069) Monocytes/100 leukocytes in Blood
364
2834
1.57
8.16
7.6
5.6
%
8.0
7.9
0.35
352
2668
(3023368) Bacteria identified in Blood by Culture
163
1043
1.73
8.05
4.3
3.6
—
—
—
0
0
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
90
481
2.00
7.87
3.9
3.4
pmol/l
4.5
4.6
0.23
80
433
(3022096) Basophils/100 leukocytes in Blood
349
2706
1.56
7.87
7.5
5.4
%
0.7
0.7
0.26
334
2525
(3002030) Lymphocytes/100 leukocytes in Blood
373
2946
1.55
7.67
7.4
5.4
%
30.2
29.7
0.41
358
2766
(3013826) Glucose [Moles/volume] in Serum or Plasma
372
2943
1.54
7.55
5.4
3.8
mmol/l
6.3
6.3
0.22
347
2664
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
115
681
1.82
7.36
1.9
1.7
—
—
—
0
0
(3018010) Neutrophils/100 leukocytes in Blood
368
2917
1.53
7.32
6.9
5.2
%
56.3
56.4
0.05
355
2745
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
27
85
3.26
7.18
2.9
2.4
—
—
—
0
0
(3002032) Base excess in Venous blood by calculation
64
313
2.15
7.09
3.4
3.6
mmol/l
2.2
1.9
0.29
49
244
(3008757) Leukocyte morphology finding [Identifier] in Blood
15
32
4.77
6.71
2.2
3.9
—
—
—
0
0
(3012544) pH of Venous blood
64
321
2.09
6.65
3.4
3.6
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
134
855
1.70
6.59
2.4
2.9
ng/l
697.1
586.8
0.18
117
703
(3009343) pH of Capillary blood
49
222
2.30
6.54
4.8
3.1
ph
7.4
7.4
—
5
28
(3032080) INR in Blood by Coagulation assay
222
1606
1.55
6.54
6.0
5.1
inr
1.1
1.1
0.15
56
549
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
79
433
1.93
6.42
1.7
1.6
—
—
—
0
0
(3022313) Gas panel - Capillary blood
37
149
2.56
6.37
5.1
3.7
—
—
—
0
0
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
14
30
4.74
6.23
3.1
2.2
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
513
4455
1.52
6.04
5.4
3.8
mm/h
11.2
9.7
2.24
485
4190
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
254
1918
1.50
6.04
2.0
1.8
pmol/l
93.8
99.1
0.92
135
1023
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
46
212
2.25
5.92
4.9
3.1
mmol/l
1.1
1.3
0.21
34
157
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
225
1663
1.51
5.90
2.5
2.3
u/l
85.7
54.9
0.57
206
1546
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
59
303
2.03
5.78
1.6
1.6
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
646
5949
1.82
5.76
6.5
4.9
mu/l
1.7
1.7
0.86
626
5651
(3018095) Leukocytes [#/volume] in Urine
251
1909
1.48
5.69
4.0
3.1
e6/l
46.1
55.9
0.26
160
1223
(3003181) Sodium [Moles/volume] in Urine
19
56
3.46
5.62
4.3
1.3
mmol/l
75.6
60.1
0.69
14
47
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
120
775
1.66
5.60
2.2
2.2
e6/l
1.0
1.0
0.02
66
409
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
77
441
1.84
5.48
1.8
1.6
—
—
—
0
0
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
97
598
1.72
5.38
2.9
2.4
umol/l
4.4
5.6
1.41
80
503
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
14
34
4.18
5.38
2.9
2.2
%
11.3
11.2
—
7
20
(3002582) Erythrocytes [#/volume] in Urine
202
1489
1.50
5.28
3.3
2.7
e6/l
29.2
57.1
1.07
148
1105
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
25
91
2.81
5.25
1.6
1.3
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
25
91
2.81
5.25
1.6
1.3
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
182
1319
1.51
5.15
1.3
1.3
iu/ml
22.2
25.3
0.17
59
434
(3021879) Hepatitis B virus core Ab [Presence] in Serum
92
566
1.72
5.14
1.4
1.4
—
—
—
0
0
(3016244) Insulin [Units/volume] in Serum or Plasma
18
55
3.33
5.05
2.2
4.1
mu/l
13.4
21.0
0.95
18
55
(3011397) Hemoglobin [Presence] in Urine by Test strip
184
1342
1.50
5.04
3.5
3.1
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
96
602
1.69
5.00
2.0
1.5
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
185
1353
1.49
4.99
3.1
2.5
e6/l
0.2
0.3
1.97
129
991
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
122
814
1.60
4.98
3.2
2.3
mmol/l
2.4
2.4
0.82
105
721
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
95
596
1.68
4.94
2.6
2.2
%
23.0
24.2
0.33
82
508
(3021589) Normoblasts [#/volume] in Blood
325
2648
1.41
4.91
8.9
7.5
e9/l
0.0
0.0
0.35
271
2182
(3026008) Bacteria identified in Urine by Culture
218
1659
1.45
4.78
2.5
2.3
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
157
1121
1.51
4.73
3.5
3.2
mg/l
520.7
378.3
0.11
95
687
(3031040) Bacteria [#/volume] in Urine by Automated count
461
4008
1.42
4.70
4.6
3.8
e6/l
124.2
709.6
—
5
47
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
194
1449
1.46
4.68
1.9
1.6
mmol/l
1.5
1.3
1.61
176
1257
(36304419) Bacteria [Presence] in Urine
184
1361
1.47
4.66
3.0
2.5
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
147
1041
1.52
4.60
1.6
1.4
nmol/l
19.8
21.8
1.08
133
922
(3017446) Testosterone [Moles/volume] in Serum or Plasma
19
64
3.02
4.58
1.4
1.3
nmol/l
0.8
2.1
1.28
14
52
(3023103) Potassium [Moles/volume] in Serum or Plasma
647
6033
1.70
4.55
16.0
9.7
mmol/l
3.9
3.9
0.19
634
5864
(3019550) Sodium [Moles/volume] in Serum or Plasma
645
6011
1.68
4.53
15.9
9.6
mmol/l
139.7
139.6
0.16
632
5857
(3004789) Transferrin [Mass/volume] in Serum or Plasma
103
675
1.61
4.52
2.3
2.1
g/l
2.5
2.5
0.43
95
620
(3009508) Creatinine [Moles/volume] in Urine
182
1352
1.46
4.49
3.7
3.0
mmol/l
7.2
7.5
0.40
157
1174
(3017143) Hepatitis C virus Ab [Presence] in Serum
130
906
1.53
4.37
1.4
1.5
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
64
373
1.79
4.33
9.8
7.5
mmol/l
0.6
1.1
0.37
57
286
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
173
1282
1.46
4.31
1.2
1.3
u/ml
20.6
12.2
0.59
64
529
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
107
719
1.57
4.23
2.7
2.3
e6/l
3.2
4.8
1.04
52
353
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
184
1388
1.44
4.16
2.1
2.0
u/l
136.8
134.0
0.04
178
1322
(40758558) Short blood count panel - Blood
198
1517
1.42
4.10
6.9
6.1
—
—
—
0
0
(3011412) CD3 cells [#/volume] in Blood
15
47
3.24
4.07
3.1
3.1
e9/l
0.9
1.1
—
10
24
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
20
75
2.71
4.02
3.1
1.8
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
476
4218
1.38
3.97
5.0
3.8
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
159
1177
1.45
3.96
4.6
3.8
mg/mmol
13.2
10.7
0.12
90
710
(3023520) Reticulocytes [#/volume] in Blood
47
256
1.89
3.95
2.9
2.9
e9/l
82.4
71.8
0.99
32
186
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
41
213
1.98
3.95
1.2
1.3
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
614
5699
1.52
3.89
13.0
8.3
ml/min/173m2
90.0
90.7
0.37
515
4632
(4281824)
20
77
2.64
3.83
1.2
1.1
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
168
1264
1.43
3.82
2.9
2.2
umol/l
3800.2
4306.0
0.07
150
1123
(3021901) Oxygen saturation in Capillary blood
17
60
2.88
3.81
2.3
1.9
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
13
39
3.38
3.77
3.2
3.3
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
65
398
1.70
3.72
3.2
4.1
ug/l
7.1
21.2
0.57
47
297
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
29
135
2.20
3.72
1.1
1.3
—
—
—
0
0
(3000850) Epithelial cells [#/volume] in Urine
141
1035
1.45
3.65
2.8
2.3
e6/l
8.4
9.4
0.24
118
909
(3044640) Blood type and Crossmatch panel - Blood
225
1796
1.37
3.59
2.4
2.0
—
—
—
0
0
(4010399)
59
356
1.72
3.57
1.5
1.3
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
173
1328
1.40
3.49
2.4
2.0
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
208
1649
1.37
3.44
2.4
2.7
ng/l
13.5
24.1
1.28
101
769
(3021601) Nitrite [Presence] in Urine by Test strip
355
3051
1.32
3.39
5.0
4.2
estimate
0.0
0.0
0.50
63
589
(3005719) IgG [Mass/volume] in Serum or Plasma
67
425
1.64
3.37
4.0
2.5
g/l
9.7
10.2
0.48
59
393
(3026782) Osmolality of Urine
127
928
1.45
3.36
3.6
2.3
mosm/kgh2o
512.2
530.0
0.37
102
794
(3022948) Iron [Moles/volume] in Serum or Plasma
107
759
1.48
3.30
2.4
2.1
umol/l
13.7
14.7
0.88
101
698
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
42
235
1.84
3.29
3.2
1.9
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
357
3080
1.31
3.28
3.8
3.1
estimate
0.0
0.0
0.80
63
580
(3000494) Fungus identified in Specimen by Culture
95
660
1.51
3.24
1.6
1.3
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
23
104
2.25
3.19
1.3
1.2
—
—
—
0
0
(3027945) Reticulocytes/100 erythrocytes in Blood
61
385
1.64
3.14
4.0
2.8
%
2.0
1.7
0.94
54
341
(3052851) Hemolysis interference index of Serum or Plasma
29
145
2.04
3.14
3.7
2.9
—
—
—
0
0
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
40
224
1.83
3.13
2.9
1.7
g/l
1.2
1.2
0.33
40
210
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
37
203
1.87
3.09
1.4
1.5
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
94
662
1.48
3.01
2.4
1.8
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
80
546
1.52
2.97
5.2
4.7
—
—
—
0
0
(3022217) INR in Platelet poor plasma by Coagulation assay
62
399
1.61
2.97
15.6
10.4
inr
1.1
1.2
0.09
16
71
(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum
7
13
5.43
2.87
3.4
2.3
ug/l
71.2
98.9
—
7
13
(3035350) Ketones [Presence] in Urine by Test strip
349
3039
1.29
2.86
3.8
3.1
estimate
0.0
0.0
0.50
62
572
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
678
6512
1.68
2.83
12.0
8.4
u/l
25.3
23.6
1.26
669
6331
(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma
42
247
1.74
2.82
1.5
1.4
pmol/l
69.8
137.7
0.77
42
241
(3003327) Ova and parasites identified in Stool by Light microscopy
45
270
1.71
2.82
1.6
1.8
—
—
—
0
0
(21494814) CD8 cells/100 lymphocytes in Specimen
7
14
5.04
2.73
3.6
2.5
—
—
—
0
0
(3016228) CD19 cells/100 cells in Blood
7
14
5.04
2.73
3.6
2.6
%
8.7
5.4
—
7
14
(3019309) Folate [Moles/volume] in Red Blood Cells
97
702
1.44
2.71
1.7
1.6
nmol/l
1128.1
1166.9
0.17
80
542
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
17
73
2.36
2.67
1.2
1.3
—
—
—
0
0
(3019060) Gas panel - Arterial blood
35
199
1.80
2.65
5.2
5.5
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
35
200
1.79
2.61
1.9
2.0
—
—
—
0
0
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
74
512
1.50
2.60
2.1
2.3
u/l
56.5
34.7
0.39
64
424
(40765096) Chromosome analysis panel by Banding
5
7
7.18
2.55
1.0
1.0
—
—
—
0
0
(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum
23
115
2.03
2.53
1.3
1.1
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
25
454
0.53
2.51
1.4
1.5
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
649
6198
1.47
2.50
15.9
10.1
mg/l
18.2
18.5
0.11
536
4701
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
30
166
1.84
2.48
14.2
10.3
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
15
63
2.41
2.47
1.7
2.2
—
—
—
0
0
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
34
196
1.77
2.47
1.6
1.6
iu/ml
0.3
0.3
—
8
32
(3019230) Fractional oxyhemoglobin in Venous blood
12
45
2.69
2.46
1.8
1.6
%
72.7
62.5
0.88
12
45
(3048689) Calprotectin [Mass/mass] in Stool
119
909
1.37
2.45
2.3
2.4
ug/g
152.3
94.9
0.89
94
708
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
53
787
0.65
2.43
1.4
1.5
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
10
34
2.97
2.42
1.0
1.0
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
83
597
1.44
2.41
1.2
1.2
—
—
—
0
0
(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma
7
17
4.15
2.36
1.3
1.1
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
606
5735
1.35
2.33
4.3
3.5
mmol/l
5.6
5.6
0.17
579
5387
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
16
72
2.25
2.29
1.0
1.1
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
11
41
2.71
2.28
1.4
1.3
—
—
—
0
0
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
8
23
3.51
2.27
1.0
1.1
—
—
—
0
0
(43055514) Macroprolactin [Presence] in Serum or Plasma
7
18
3.92
2.25
1.1
1.2
—
—
—
0
0
(3030981) Hyaline casts [#/volume] in Urine by Automated count
37
225
1.68
2.25
3.2
2.4
e6/l
0.1
0.2
1.31
37
212
(4035726)
65
452
1.48
2.25
1.5
1.4
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
22
400
0.54
2.24
1.5
1.5
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
31
180
1.75
2.22
1.8
1.9
—
—
—
0
0
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
5
9
5.58
2.21
3.4
3.0
—
—
—
0
0
(3030905) Polymorphonuclear cells [#/volume] in Blood
23
122
1.91
2.18
3.8
3.8
e9/l
3.3
4.3
2.48
23
122
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
23
122
1.91
2.18
1.3
1.5
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
194
1615
1.28
2.16
4.2
3.4
estimate
0.0
0.0
1.08
62
590
(40768797) Stomach Pathology biopsy report
100
762
1.36
2.10
1.3
1.2
—
—
—
0
0
(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)
8
25
3.22
2.10
3.0
1.5
nmol/l
1.7
2.4
—
8
19
(3000492) Spirometry study
83
615
1.40
2.06
1.5
1.4
—
—
—
0
0
(1616796) Gas panel - Central venous blood
17
83
2.07
2.02
2.5
2.0
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
474
4380
1.24
2.01
2.9
2.8
u/l
37.2
34.8
0.37
457
4201
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
23
126
1.85
2.00
4.0
4.0
%
52.8
58.0
1.50
23
126
(40761535) Cells panel - Urine sediment
57
397
1.47
1.98
3.8
3.2
—
—
—
0
0
(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum
36
226
1.62
1.97
1.2
1.2
u/ml
38.7
16.1
—
6
13
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
17
84
2.05
1.97
3.8
5.8
u/ml
0.3
0.4
1.04
12
45
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
8
185
0.43
1.95
1.1
1.1
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
38
576
0.64
1.94
1.2
1.4
—
—
—
0
0
(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma
5
11
4.57
1.94
1.4
1.1
u/l
8.8
14.1
—
5
11
(3014051) Protein [Presence] in Urine by Test strip
24
135
1.80
1.93
2.0
1.6
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
10
39
2.59
1.92
2.9
2.6
—
—
—
0
0
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
33
204
1.65
1.92
1.2
1.2
u/ml
4.2
2.3
—
5
24
(40768804) Tissue Pathology biopsy report
306
2712
1.22
1.91
2.3
1.9
—
—
—
0
0
(3038026) Centromere Ab [Units/volume] in Serum
12
52
2.33
1.88
1.3
1.2
—
106.9
—
0
6
(3006653) Thiamine [Moles/volume] in Blood
7
22
3.20
1.88
1.0
1.8
nmol/l
127.0
138.5
—
7
22
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
62
444
1.43
1.88
4.3
2.1
ml/min/173m2
67.0
79.8
1.10
24
163
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
15
72
2.11
1.87
1.4
1.6
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
13
59
2.23
1.85
1.3
1.4
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
172
1437
1.26
1.84
1.9
1.8
mg/l
0.8
0.8
0.09
126
1075
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
77
575
1.38
1.84
3.7
3.4
%
33.9
32.3
0.59
67
417
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
23
130
1.79
1.83
1.2
1.4
u/ml
286.9
227.5
0.36
14
88
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
321
2869
1.21
1.82
4.2
3.8
—
—
—
0
0
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
7
23
3.06
1.80
1.0
1.0
—
—
—
0
0
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
33
208
1.61
1.80
1.2
1.3
u/ml
1.4
13.0
—
6
43
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
6
18
3.35
1.75
3.3
3.1
—
—
—
0
0
(3010254) Herpes simplex virus identified in Specimen by Organism specific culture
6
18
3.35
1.75
1.2
1.1
—
—
—
0
0
(3010421) pH of Blood
19
103
1.87
1.73
2.3
2.2
ph
7.4
7.4
1.65
12
84
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
77
585
1.35
1.67
2.0
2.1
u/l
1542.3
6061.5
2.47
32
248
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
162
1359
1.25
1.67
2.2
2.1
mg/l
2.8
2.7
0.35
140
1178
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
60
808
0.72
1.67
1.6
1.6
—
—
—
0
0
(3019225) pH of Specimen
60
438
1.40
1.66
3.4
3.0
—
—
—
0
0
(3005895) Myoglobin [Mass/volume] in Serum or Plasma
20
112
1.81
1.66
3.7
2.2
ug/l
442.2
185.3
0.40
15
99
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
27
422
0.63
1.61
1.4
1.4
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
16
84
1.93
1.60
1.6
1.3
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
23
136
1.71
1.60
1.3
1.3
—
—
—
0
0
(4062490)
13
63
2.08
1.60
1.3
1.3
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
27
421
0.63
1.60
1.4
1.4
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
27
421
0.63
1.60
1.4
1.4
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
27
420
0.63
1.58
1.4
1.4
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
7
26
2.71
1.58
1.6
1.4
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
196
1691
1.22
1.55
1.4
1.3
u/ml
1.6
1.7
0.04
51
491
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
10
44
2.29
1.53
1.5
1.5
—
—
—
0
0
(3013512) EKG study
150
1261
1.24
1.52
3.3
2.6
—
—
—
0
0
(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma
6
21
2.87
1.51
2.0
1.6
ug/l
15.8
28.8
—
6
21
(3020876) Protein [Mass/time] in 24 hour Urine
7
28
2.51
1.45
1.9
2.5
—
1.6
—
0
5
(3043238) Trisomy 21 risk [Likelihood] in Fetus
23
362
0.62
1.44
1.3
1.5
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
594
5698
1.24
1.41
3.9
3.3
mmol/l
1.3
1.2
2.39
575
5401
(3015736) pH of Urine
263
2353
1.19
1.39
3.4
2.9
—
—
—
0
0
(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum
11
53
2.09
1.39
1.4
1.2
—
60.3
—
0
6
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
6
23
2.62
1.37
1.8
1.3
ug/l
9.9
8.2
—
6
23
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
6
23
2.62
1.37
1.0
1.3
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
37
257
1.46
1.36
1.3
1.3
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
37
520
0.70
1.35
1.4
1.4
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
37
258
1.46
1.34
1.9
1.6
—
—
—
0
0
(3028679) Herpes simplex virus Ab [Presence] in Serum
9
42
2.16
1.34
1.1
1.2
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
53
395
1.37
1.33
1.2
1.2
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
202
1772
1.19
1.33
1.6
1.6
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
11
54
2.05
1.33
1.2
1.2
nmol/l
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
23
354
0.64
1.32
1.3
1.4
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
34
234
1.48
1.32
2.4
2.3
—
—
—
0
0
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
6
24
2.51
1.30
1.0
1.0
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
23
352
0.64
1.29
1.3
1.4
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
11
55
2.02
1.28
1.2
1.1
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
9
44
2.06
1.27
1.3
1.1
—
—
—
0
0
(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay
6
25
2.41
1.24
2.8
3.1
—
136.1
—
0
6
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
10
49
2.06
1.22
1.0
1.2
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
10
49
2.06
1.22
1.7
1.4
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
164
1423
1.20
1.22
1.8
1.4
g/l
2.1
2.1
0.20
95
907
(3009871) Measles virus Ab [Titer] in Serum
5
19
2.64
1.22
1.4
1.5
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
22
334
0.65
1.20
1.8
1.7
—
—
—
0
0
(3020891) Body temperature
21
133
1.60
1.18
4.1
5.2
—
—
—
0
0
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
50
378
1.35
1.17
1.3
1.3
miu/ml
268.8
233.1
0.31
19
193
(3022145) Colonoscopy Study observation
78
628
1.27
1.17
1.3
1.3
—
—
—
0
0
(3022621) pH of Urine by Test strip
51
387
1.34
1.17
2.1
2.1
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
10
185
0.53
1.17
1.8
1.7
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
151
1306
1.20
1.16
4.0
3.3
kg/l
1.0
1.0
1.17
23
173
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
84
1023
0.80
1.16
1.4
1.4
—
—
—
0
0
(3044889) 12 lead EKG panel
407
3809
1.16
1.16
3.2
2.8
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
76
932
0.79
1.12
1.3
1.3
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
106
1252
0.82
1.10
1.6
1.7
—
—
—
0
0
(3036489) Thrombin time
32
229
1.42
1.05
2.4
2.2
s
20.3
20.6
0.17
26
195
(3024980) IgG subclass 4 [Mass/volume] in Serum
15
90
1.68
1.04
1.7
1.6
g/l
0.5
0.8
—
7
68
(3034770) Mitochondria Ab [Titer] in Serum
24
163
1.49
1.03
1.3
1.2
—
858.2
—
0
11
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
9
48
1.89
1.00
1.3
1.1
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
355
3313
1.14
1.00
3.0
2.8
ug/l
80.8
65.4
1.16
338
3143
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
117
1004
1.20
0.99
1.6
1.6
pmol/l
406.4
62921778.4
2.30
102
890
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
262
2397
1.15
0.99
3.8
3.1
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
7
134
0.52
0.99
3.7
1.1
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
543
5219
1.16
0.99
5.3
4.2
mmol/mol
38.2
37.7
0.57
511
4933
(3025018) Bordetella pertussis Ab [Titer] in Serum
9
49
1.85
0.99
1.4
1.2
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
38
284
1.36
0.99
2.2
1.6
—
—
—
0
0
(40768793) Breast Pathology biopsy report
30
216
1.41
0.97
1.3
1.3
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
10
54
1.86
0.97
7.5
3.0
—
—
—
0
0
(3024139) IgG subclass 3 [Mass/volume] in Serum
11
62
1.79
0.94
1.2
1.3
g/l
0.4
0.4
—
5
45
(3028192) IgG subclass 2 [Mass/volume] in Serum
11
62
1.79
0.94
1.2
1.3
g/l
2.7
2.9
—
5
44
(3027135) IgG subclass 1 [Mass/volume] in Serum
11
62
1.79
0.94
1.2
1.3
g/l
5.3
6.7
—
5
45
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
7
37
1.90
0.94
1.7
2.1
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
621
6042
1.20
0.93
4.6
3.8
mmol/l
2.9
2.9
0.05
589
5714
(3024891) Influenza virus A+B Ag [Presence] in Specimen
28
201
1.41
0.92
1.3
1.1
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
13
78
1.68
0.92
2.3
1.3
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
18
118
1.54
0.91
1.1
1.4
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
55
440
1.27
0.90
4.0
3.8
%
0.5
1.1
1.88
22
95
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
6
29
2.08
0.89
1.3
1.3
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
6
29
2.08
0.89
1.2
1.2
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
12
71
1.70
0.89
1.8
1.7
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
615
5985
1.19
0.88
4.5
3.6
mmol/l
4.9
4.9
0.91
595
5707
(40760892) CBC W Ordered Manual Differential panel - Blood
176
1581
1.15
0.86
5.2
3.8
—
—
—
0
0
(4146454)
6
31
1.94
0.84
3.8
2.5
—
—
—
0
0
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
27
364
0.73
0.83
1.3
1.7
mg/l
3.2
3.1
0.07
21
241
(3023419) Bacteria identified in Sputum by Culture
8
46
1.75
0.82
1.0
2.1
—
—
—
0
0
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
8
46
1.75
0.82
1.8
1.4
g/l
1.1
0.9
—
8
46
(3042111) Morphology [Interpretation] in Bone marrow Narrative
8
46
1.75
0.82
1.3
1.3
—
—
—
0
0
(4306422)
16
105
1.54
0.82
1.1
1.2
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
16
105
1.54
0.82
1.8
1.7
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
22
305
0.71
0.81
1.6
2.0
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
31
234
1.34
0.79
2.6
1.7
—
—
—
0
0
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
13
82
1.60
0.78
1.1
1.1
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
16
107
1.51
0.76
1.8
1.6
—
—
—
0
0
(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid
6
34
1.77
0.76
1.2
1.7
%
—
64.6
—
0
5
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
56
460
1.24
0.76
1.6
1.5
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
55
451
1.24
0.76
2.5
2.3
e9/l
4.6
4.0
0.74
43
388
(3025159) Blasts/100 leukocytes in Blood
49
397
1.25
0.75
4.3
4.0
%
0.0
1.3
0.54
19
66
(3004716) Salmonella sp identified in Stool by Organism specific culture
55
452
1.23
0.75
1.4
1.5
—
—
—
0
0
(3011648) Oxygen content in Venous blood
5
24
2.09
0.74
2.2
1.6
%
13.9
10.8
—
5
24
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
611
5962
1.16
0.74
4.4
3.5
mmol/l
1.6
1.6
1.28
591
5658
(3028707) Methadone [Presence] in Urine by Screen method
12
183
0.65
0.73
4.5
2.2
—
—
—
0
0
(21494434) Karyotype in Bone marrow
5
25
2.01
0.73
1.4
1.2
—
—
—
0
0
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
5
25
2.01
0.73
1.0
1.0
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
62
737
0.83
0.72
1.5
1.7
—
—
—
0
0
(44806118)
9
56
1.61
0.72
1.8
1.4
—
—
—
0
0
(44790047)
9
56
1.61
0.72
1.8
1.4
—
—
—
0
0
(44790049)
9
56
1.61
0.72
1.8
1.4
—
—
—
0
0
(44790048)
9
56
1.61
0.72
1.8
1.4
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
9
56
1.61
0.72
1.0
1.2
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
10
60
1.68
0.72
1.2
1.2
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
55
455
1.23
0.71
3.3
2.6
—
—
—
0
0
(3043409) Potassium [Moles/volume] in Arterial blood
15
101
1.50
0.70
3.7
4.4
mmol/l
3.9
3.7
1.84
15
96
(3035320) C reactive protein [Mass/volume] in Body fluid
7
41
1.71
0.70
2.0
1.9
—
—
—
0
0
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
13
85
1.54
0.69
1.1
1.1
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
12
77
1.57
0.69
1.3
1.4
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
10
61
1.65
0.68
1.2
1.2
—
—
—
0
0
(40757494) Bilirubin.total [Moles/volume] in Blood
5
27
1.86
0.68
1.4
2.1
—
16.0
—
0
5
(3037756) Immunofixation for Serum or Plasma
9
59
1.53
0.68
2.1
1.6
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
7
42
1.67
0.68
1.6
1.9
—
—
—
0
0
(40768443) Skin Pathology biopsy report
30
232
1.31
0.67
1.2
1.1
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
22
292
0.75
0.65
1.5
1.5
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
169
1545
1.12
0.64
1.6
1.7
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
5
29
1.73
0.64
1.6
1.4
—
—
—
0
0
(3025443) Phadiatop IgE Ab [Units/volume] in Serum
5
29
1.73
0.64
1.2
1.1
—
12.1
—
0
5
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
537
5214
1.12
0.63
3.8
3.7
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
186
2015
0.90
0.63
1.6
1.7
—
—
—
0
0
(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence
12
79
1.53
0.63
1.1
1.3
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
8
49
1.64
0.62
1.5
1.8
—
—
—
0
0
(3036071) Salmonella sp Ab [Titer] in Serum
5
30
1.67
0.61
1.0
1.1
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
8
50
1.61
0.61
1.0
1.1
—
—
—
0
0
(3000012) Reticulocyte production index
0
21
0.00
0.60
0.0
1.7
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
50
419
1.21
0.59
4.2
3.9
%
0.0
0.1
0.72
21
84
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
10
64
1.57
0.59
1.8
1.4
—
—
—
0
0
(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay
15
106
1.42
0.58
1.2
1.1
%
123.9
116.1
0.44
15
95
(46235355) HIV 1 and 2 tests - Meaningful Use set
200
1857
1.11
0.58
1.8
1.9
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
183
1975
0.90
0.58
1.6
1.5
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
63
542
1.18
0.57
3.4
3.1
—
—
—
0
0
(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay
6
36
1.67
0.56
1.0
1.1
%
104.7
86.4
—
6
28
(3017817) Protein [Mass] in Urine collected for unspecified duration
6
36
1.67
0.56
3.2
1.8
—
—
—
0
0
(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma
6
36
1.67
0.56
1.5
1.1
%
126.0
113.6
—
6
28
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
28
221
1.28
0.56
1.8
2.0
iu/l
5.2
5.0
—
9
92
(3009466) Valproate [Moles/volume] in Serum or Plasma
5
90
0.55
0.56
5.0
6.2
umol/l
322.6
381.2
—
5
78
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
10
65
1.55
0.55
1.2
1.1
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
10
65
1.55
0.55
1.2
1.1
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
10
65
1.55
0.55
1.2
1.1
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
13
90
1.45
0.55
2.5
2.8
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
6
37
1.63
0.55
1.0
1.2
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
8
126
0.63
0.54
1.4
1.9
—
—
—
0
0
(3006922) Hepatitis E virus Ab [Presence] in Serum
6
38
1.58
0.54
1.0
1.1
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
9
61
1.48
0.54
1.7
1.4
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
24
187
1.29
0.53
1.2
1.2
—
—
—
0
0
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
19
143
1.34
0.53
1.2
1.6
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
10
66
1.52
0.52
1.2
1.1
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
10
66
1.52
0.52
1.2
1.1
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
10
66
1.52
0.52
1.2
1.1
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
10
66
1.52
0.52
1.0
1.5
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
28
347
0.80
0.52
2.7
1.8
—
—
—
0
0
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
6
40
1.50
0.51
1.5
1.8
pg
31.5
31.5
—
6
40
(40768441) Liver Pathology biopsy report
6
40
1.50
0.51
1.3
1.5
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
9
64
1.41
0.51
1.1
1.5
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
9
64
1.41
0.51
1.1
1.5
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
9
64
1.41
0.51
1.1
1.5
—
—
—
0
0
(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma
6
41
1.47
0.50
1.7
1.1
g/l
0.4
0.3
—
6
35
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
25
198
1.27
0.50
1.5
1.5
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
10
67
1.50
0.50
1.1
1.5
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
10
67
1.50
0.50
1.1
1.5
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
118
1291
0.90
0.49
2.0
2.0
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
24
190
1.27
0.48
1.2
1.2
—
—
—
0
0
(3006442) Creatine [Moles/volume] in Serum or Plasma
7
47
1.49
0.47
2.3
1.4
—
62.8
—
0
6
(1761868) Lipid panel - Serum or Plasma
242
2554
0.92
0.47
2.5
2.3
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
32
384
0.83
0.45
2.5
1.7
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
19
147
1.30
0.45
1.1
1.2
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
7
51
1.38
0.44
2.4
1.5
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
7
51
1.38
0.44
1.1
2.5
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
32
382
0.83
0.44
2.4
1.7
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
32
382
0.83
0.44
2.5
1.7
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
11
78
1.42
0.43
1.1
1.1
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
11
78
1.42
0.43
1.1
1.2
—
—
—
0
0
(3029396) Erythrocyte agglutination [Presence] in Blood
5
31
1.62
0.43
2.2
3.6
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
668
6607
1.15
0.41
13.7
9.3
—
—
—
0
0
(3036603) Volume of Urine
5
33
1.52
0.41
2.0
1.6
—
2327.0
—
0
6
(3000570) Elastase.pancreatic [Mass/mass] in Stool
21
168
1.26
0.40
1.5
1.3
ug/g
335.1
329.4
0.03
12
86
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
10
71
1.41
0.39
2.2
1.4
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
49
430
1.15
0.38
1.7
1.7
—
—
—
0
0
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
5
36
1.39
0.38
5.2
8.1
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
23
188
1.23
0.38
1.2
1.2
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
86
941
0.90
0.37
1.8
1.8
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
5
37
1.35
0.37
1.0
1.1
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
5
37
1.35
0.37
1.0
1.1
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
32
272
1.18
0.36
1.7
1.6
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
32
374
0.85
0.36
2.4
1.7
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
13
99
1.32
0.35
1.2
1.1
—
—
—
0
0
(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum
9
126
0.71
0.35
1.0
1.1
—
9.7
—
0
14
(3037121) Protein [Mass/volume] in Urine
20
163
1.23
0.34
6.9
3.1
g/l
0.3
0.3
0.04
14
57
(3002385) Erythrocyte distribution width [Ratio]
555
5456
1.07
0.33
18.0
12.1
%
13.6
13.5
0.40
549
5357
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
49
436
1.13
0.33
1.1
1.0
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
25
211
1.19
0.32
1.2
1.1
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
60
661
0.90
0.31
1.9
1.7
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
26
221
1.18
0.31
1.4
1.3
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
84
909
0.91
0.30
1.7
2.0
—
—
—
0
0
(4034850)
22
184
1.20
0.30
5.5
5.9
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
7
54
1.30
0.30
1.1
1.1
—
—
—
0
0
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
7
54
1.30
0.30
1.1
1.3
—
—
—
0
0
(3000475) Leukocytes [#/volume] in Synovial fluid
13
102
1.28
0.30
1.8
1.7
e6/l
3731.8
12145.0
—
8
78
(3045683) HLA typing for celiac disease panel - Blood or Tissue
7
56
1.25
0.29
1.0
1.0
—
—
—
0
0
(3002256) Pathology report gross observation
86
797
1.09
0.29
1.2
1.2
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
8
62
1.29
0.28
1.1
1.1
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
8
65
1.23
0.27
1.1
1.9
—
—
—
0
0
(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay
8
66
1.21
0.26
4.8
3.4
u/ml
17.2
74.7
—
8
66
(3023410) Appearance of Cerebral spinal fluid
5
71
0.70
0.26
1.2
2.0
—
—
—
0
0
(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay
10
77
1.30
0.26
1.1
1.1
%
99.9
94.2
—
10
72
(3044290) Cell count panel - Cerebral spinal fluid
16
132
1.22
0.26
1.1
1.9
—
—
—
0
0
(3026361) Erythrocytes [#/volume] in Blood
703
6996
1.18
0.25
22.5
15.1
e12/l
4.4
4.5
2.06
692
6867
(3002179) Metamyelocytes/100 leukocytes in Blood
45
407
1.11
0.25
3.6
3.7
%
0.2
0.9
2.11
17
65
(1001926) Buprenorphine [Presence] in Urine by Screen method
27
306
0.88
0.23
2.7
1.7
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
12
97
1.24
0.23
1.2
1.2
—
—
—
0
0
(3010813) Leukocytes [#/volume] in Blood
703
6999
1.17
0.22
22.5
15.1
e9/l
6.5
6.7
0.76
691
6859
(3007461) Platelets [#/volume] in Blood
702
6989
1.16
0.22
22.5
15.1
e9/l
270.0
268.9
0.19
690
6871
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
5
41
1.22
0.22
1.8
1.8
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
5
41
1.22
0.22
1.8
1.8
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
5
41
1.22
0.22
1.8
1.8
—
—
—
0
0
(4024509)
5
42
1.19
0.21
1.2
1.4
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
49
450
1.10
0.21
1.2
1.2
—
—
—
0
0
(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3004451) EKG impression Narrative
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
(3017509) Phencyclidine [Presence] in Urine
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
(3047189) Immunofixation for 24 hour Urine
0
12
0.00
0.21
0.0
2.2
—
—
—
0
0
(3032567) Hepatitis B virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
0
13
0.00
0.21
0.0
1.8
—
—
—
0
0
(44806071)
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
(40760435) Tropomyosin IgE Ab [Units/volume] in Serum
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
607
6013
1.06
0.21
15.6
10.7
%
39.2
39.6
0.90
482
4958
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
47
433
1.09
0.19
1.7
1.5
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
14
118
1.19
0.19
1.1
1.1
—
—
—
0
0
(3051387) C reactive protein [Mass/volume] in Capillary blood
14
118
1.19
0.19
3.5
3.2
mg/l
14.5
24.6
—
6
73
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
10
122
0.82
0.19
2.3
1.6
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
11
132
0.83
0.18
1.5
1.1
—
—
—
0
0
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
7
63
1.11
0.17
1.1
1.1
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
138
1431
0.96
0.16
2.0
2.1
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
8
69
1.16
0.16
1.6
2.0
—
—
—
0
0
(1617658) Protocol used for examination of sentinel lymph nodes
9
79
1.14
0.15
1.0
1.1
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
9
81
1.11
0.15
1.2
1.7
—
—
—
0
0
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
22
198
1.11
0.14
1.1
1.1
u/ml
0.5
1.4
—
10
72
(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay
15
131
1.15
0.14
1.0
1.1
u/ml
2.0
2.7
—
5
64
(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal
8
96
0.83
0.14
1.4
1.5
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
24
263
0.91
0.13
3.2
2.3
—
—
—
0
0
(3020044) Glucose [Moles/volume] in Cerebral spinal fluid
16
142
1.13
0.12
1.1
1.5
mmol/l
3.9
3.7
0.22
16
132
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
81
842
0.96
0.11
1.5
1.5
%
1.5
1.3
1.89
76
766
(1002224) Polysomnography panel
30
322
0.93
0.11
1.0
1.1
—
—
—
0
0
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
14
125
1.12
0.10
1.2
1.2
u/ml
5.0
3.3
—
7
49
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
5
44
1.14
0.10
1.0
1.9
—
—
—
0
0
(3019420) Tryptase [Mass/volume] in Serum or Plasma
5
46
1.09
0.09
10.4
1.7
ug/l
74.4
6.2
—
5
38
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
5
47
1.06
0.09
1.0
1.0
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
11
97
1.14
0.09
1.0
1.0
—
—
—
0
0
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
5
62
0.81
0.08
1.0
1.9
—
—
—
0
0
(3005570) Glucose [Moles/volume] in Urine
5
64
0.78
0.08
2.4
2.7
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
7
65
1.08
0.08
1.7
1.8
—
—
—
0
0
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
6
72
0.83
0.07
1.0
1.1
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
6
72
0.83
0.07
1.3
1.5
—
—
—
0
0
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
6
75
0.80
0.07
1.0
1.3
—
—
—
0
0
(4268621)
8
78
1.03
0.07
2.4
2.1
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
12
131
0.91
0.05
1.2
1.3
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
22
232
0.95
0.05
2.7
2.2
—
—
—
0
0
(3003888) Timothy IgE Ab [Units/volume] in Serum
17
181
0.94
0.05
1.0
1.1
u/ml
0.2
4.0
2.90
11
93
(3008401) Mugwort IgE Ab [Units/volume] in Serum
16
169
0.95
0.03
1.0
1.1
u/ml
0.3
0.6
—
9
66
(3045424) Erythrocytes [Presence] in Urine
10
108
0.92
0.03
2.0
1.6
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
11
103
1.07
0.02
1.1
1.1
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
180
1794
1.00
0.00
3.5
2.7
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
10
105
0.95
0.00
1.9
1.9
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
13
125
1.04
0.00
1.0
1.1
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
13
125
1.04
0.00
1.2
1.1
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
10
97
1.03
0.00
2.4
2.9
—
—
—
0
0
(3008898) HLA-B27 [Presence]
36
363
0.99
0.00
1.1
1.1
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
12
121
0.99
0.00
1.4
1.4
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
16
159
1.01
0.00
1.3
1.1
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
16
159
1.01
0.00
1.3
1.1
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
34
341
1.00
0.00
1.3
1.3
—
—
—
0
0
(3028717) Thiamine [Mass/volume] in Blood
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
(3052592) Norovirus Ag [Presence] in Stool
0
8
0.00
0.00
0.0
1.5
—
—
—
0
0
(3012984) Norclozapine [Mass/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
8.9
—
—
—
0
0
(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(4027681)
5
51
0.98
0.00
1.4
1.2
—
—
—
0
0
(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3051339) Copper [Moles/volume] in Blood
0
6
0.00
0.00
0.0
1.2
—
16.7
—
0
6
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
0
9
0.00
0.00
0.0
2.2
—
—
—
0
0
(3032773) Endomysium IgG Ab [Titer] in Serum
7
75
0.93
0.00
1.0
1.1
—
—
—
0
0
(3022475) Manganese [Moles/volume] in Blood
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(44813793)
5
57
0.88
0.00
1.0
1.1
—
—
—
0
0
(3014064) Pregnancy associated plasma protein A [Multiple of the median] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3034037) Hematocrit [Volume Fraction] of Mixed venous blood
0
5
0.00
0.00
0.0
3.8
—
—
—
0
0
(3000285) Sodium [Moles/volume] in Blood
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3027974) Hepatitis B virus e Ag [Presence] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(40765091) Chromosome analysis panel - Chorionic villus sample by G-banded
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3051101) Glucose [Moles/volume] in Cord blood
0
7
0.00
0.00
0.0
2.4
—
—
—
0
0
(3022806) Fractional oxyhemoglobin in Capillary blood
5
51
0.98
0.00
1.6
1.5
%
93.5
91.6
—
5
51
(3032700) Glomerular basement membrane Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma
5
57
0.88
0.00
1.2
1.2
u/l
7.5
15.2
—
5
46
(40763480) Human metapneumovirus Ag [Presence] in Specimen
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
2.0
—
—
—
0
0
(3032868) Hemoglobin electrophoresis panel in Blood
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3027653) Mycophenolate [Mass/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
3.5
—
3.4
—
0
6
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
8
82
0.98
0.00
1.1
1.4
—
—
—
0
0
(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
0
9
0.00
0.00
0.0
2.2
—
—
—
0
0
(4094501)
12
120
1.00
0.00
1.3
1.0
—
—
—
0
0
(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3048879) Bone marrow aspiration report
0
5
0.00
0.00
0.0
5.0
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint E4_OVARFAIL and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| E4_OVARFAIL | 2.676 [2.14, 3.35] | < 0.001 |
| Birth year | 0.992 [0.98, 1.0] | 0.077 |
During the follow-up period (1.1.1998 — 31.12.2019), 93 out of 2006 females with E4_OVARFAIL died.
Males
No dataMortality risk
Mortality risk for people of age
years, who have E4_OVARFAIL.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.258% | No data |
| 5 | 1.402% | No data |
| 10 | 3.668% | No data |
| 15 | 7.081% | No data |
| 20 | 11.799% | No data |
Relationships between endpoints
↥Index endpoint: E4_OVARFAIL – Primary ovarian failure
GWS hits: -
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data